Alvotech Petitions US FDA To Deny Interchangeability For Rival Stelara Biosimilars

 
• By Dave Wallace
  
Alvotech wants the FDA to deny interchangeability for certain ustekinumab biosimilars. (Shutterstock)

More from Biosimilars

More from Biosimilars & Generics